Metronomic Chemotherapy Based on Adaptative Bio-mathematical Model of Oral Vinorelbine in Patients With NSCLC or MPM
PHASE1CompletedINTERVENTIONAL
Enrollment
30
Participants
Timeline
Start Date
August 26, 2015
Primary Completion Date
July 26, 2018
Study Completion Date
October 25, 2022
Conditions
Non Small Cell Lung Cancer (NSCLC)Malignant Pleural Mesothelioma (MPM)
Interventions
DRUG
Vinorelbine
Trial Locations (1)
13005
Assistance Publique des Hôpitaux de Marseille (CEPCM), Marseille
All Listed Sponsors
lead
Assistance Publique Hopitaux De Marseille
OTHER
NCT02555007 - Metronomic Chemotherapy Based on Adaptative Bio-mathematical Model of Oral Vinorelbine in Patients With NSCLC or MPM | Biotech Hunter | Biotech Hunter